Carolynn E. Ohlson
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 2
- PARP inhibition in cancer therapy 1
- Cancer survivorship and care 1
-
- PI3K/AKT/mTOR signaling in cancer 4
- Epigenetics and DNA Methylation 1
- Co-authors
- Jean J. Zhao (5 shared papers)Thomas M. Roberts (4 shared papers)Roderick Terry Bronson (2 shared papers)Hai-Ling Margaret Cheng (4 shared papers)Joyce F. Liu (1 shared paper)Hye‐Jung Kim (1 shared paper)Brooke E. Howitt (1 shared paper)Panagiotis A. Konstantinopoulos (1 shared paper)
- Journals
- Cell Reports (2 papers)Cancer Research (1 paper)Oncogene (1 paper)Proceedings of the National Academy of Sciences (1 paper)Digital WPI (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Carolynn E. Ohlson
6 papers receiving 728 citations
Peers
Comparison fields: 5 of 48
- Oncology 335
- Reproductive Medicine 64
- Immunology 101
- Cancer Research 49
- Molecular Biology 214
Countries citing papers authored by Carolynn E. Ohlson
This map shows the geographic impact of Carolynn E. Ohlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolynn E. Ohlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolynn E. Ohlson more than expected).
Fields of papers citing papers by Carolynn E. Ohlson
This network shows the impact of papers produced by Carolynn E. Ohlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolynn E. Ohlson. The network helps show where Carolynn E. Ohlson may publish in the future.
Co-authors
The 25 scholars most cited alongside Carolynn E. Ohlson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 465 | |
| 2 | 2016 | 95 | |
| 3 | 2017 | 88 | |
| 4 | 2013 | 50 | |
| 5 | 2015 | 36 | |
| 6 | Breast Cancer in Thailand: Developing Effective and Accessible Media on Integrative Therapies for Breast Cancer Patients | 2011 | 1 |
About Carolynn E. Ohlson
Carolynn E. Ohlson is a scholar working on Oncology, Molecular Biology, Complementary and alternative medicine, General Health Professions and Nuclear Energy and Engineering, having authored 6 papers that have together received 735 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Complementary and Alternative Medicine Studies (1 paper), Epigenetics and DNA Methylation (1 paper), PARP inhibition in cancer therapy (1 paper), Health Literacy and Information Accessibility (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Oncology (335 citations), Reproductive Medicine (64 citations), Immunology (101 citations), Cancer Research (49 citations) and Molecular Biology (214 citations). Carolynn E. Ohlson has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jean J. Zhao, Thomas M. Roberts, Roderick Terry Bronson, Hai-Ling Margaret Cheng, Joyce F. Liu, Hye‐Jung Kim, Brooke E. Howitt, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis and Liya Ding. Their work appears in journals such as Cell Reports, Cancer Research, Oncogene, Proceedings of the National Academy of Sciences and Digital WPI.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.